JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, A. J.
Right arrow Articles by Zhu, B. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, A. J.
Right arrow Articles by Zhu, B. T.

Vol. 300, Issue 3, 838-849, March 2002

NADPH-Dependent Metabolism of Estrone by Human Liver Microsomes

Anthony J. Lee, Laura H. Mills, Joseph W. Kosh, Allan H. Conney and Bao Ting Zhu

Department of Basic Pharmaceutical Sciences, College of Pharmacy, University of South Carolina, Columbia, South Carolina (A.J.L., L.H.M., J.W.K., B.T.Z.); and Department of Chemical Biology, College of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, New Jersey (A.H.C.)

We characterized the NADPH-dependent metabolism of estrone (E1) by liver microsomes of 21 male and 12 female human subjects. The structures of 11 hydroxylated or keto metabolites of E1 formed by human liver microsomes were identified by chromatographic and mass spectrometric analyses. 2-Hydroxylation of E1 was the dominant metabolic pathway with all human liver microsomes tested. E1 is more prone to form catechol estrogens (particularly 4-OH-E1) than 17beta -estradiol (E2) and the average ratio of E1 4-hydroxylation to 2-hydroxylation (0.24) was slightly higher than the ratio of E2 4- to 2-hydroxylation (0.20, P < 0.001). An unidentified monohydroxylated E1 metabolite (y-OH-E1) was found to be one of the major metabolites formed by human liver microsomes of both genders. 6beta -OH-E1, 16alpha -OH-E1, and 16beta -OH-E1 were also formed in significant quantities. 16alpha -Hydroxylation was not a major pathway for E1 metabolism. The overall profiles for the E1 metabolites formed by male and female human liver microsomes were similar, and their average rates were not significantly different. Hepatic CYP3A4/5 activity in both male and female liver microsomes correlated strongly with the rates of formation of several hydroxyestrogen metabolites. The dominant role of hepatic CYP3A4 and CYP3A5 in the formation of these hydroxyestrogen metabolites was further confirmed by incubations of human CYP3A4 or CYP3A5 with [3H]E1 and NADPH. Notably, human CYP3A5 has very high relative activity for E1 4-hydroxylation, exceeding its activity for E1 2-hydroxylation by ~100%. It will be of interest to determine the potential biological functions associated with any of the E1 metabolites identified in our present study.

0022-3565/02/3003-0838$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2002 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
J. A. Doherty, N. S. Weiss, R. J. Freeman, D. A. Dightman, P. J. Thornton, J. R. Houck, L. F. Voigt, M. A. Rossing, S. M. Schwartz, and C. Chen
Genetic Factors in Catechol Estrogen Metabolism in Relation to the Risk of Endometrial Cancer
Cancer Epidemiol. Biomarkers Prev., February 1, 2005; 14(2): 357 - 366.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
W. Huang, Y. S. Lin, D. J. McConn II, J. C. Calamia, R. A. Totah, N. Isoherranen, M. Glodowski, and K. E. Thummel
EVIDENCE OF SIGNIFICANT CONTRIBUTION FROM CYP3A5 TO HEPATIC DRUG METABOLISM
Drug Metab. Dispos., December 1, 2004; 32(12): 1434 - 1445.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
B. Wang, R. I. Sanchez, R. B. Franklin, D. C. Evans, and S.-E. W. Huskey
THE INVOLVEMENT OF CYP3A4 AND CYP2C9 IN THE METABOLISM OF 17{alpha}-ETHINYLESTRADIOL
Drug Metab. Dispos., November 1, 2004; 32(11): 1209 - 1212.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
A. J. Lee and B. T. Zhu
NADPH-DEPENDENT FORMATION OF POLAR AND NONPOLAR ESTROGEN METABOLITES FOLLOWING INCUBATIONS OF 17{beta}-ESTRADIOL WITH HUMAN LIVER MICROSOMES
Drug Metab. Dispos., August 1, 2004; 32(8): 876 - 883.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. J. Lee, A. H. Conney, and B. T. Zhu
Human Cytochrome P450 3A7 Has a Distinct High Catalytic Activity for the 16{alpha}-Hydroxylation of Estrone but not 17{beta}-Estradiol
Cancer Res., October 1, 2003; 63(19): 6532 - 6536.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
A. J. Lee, M. X. Cai, P. E. Thomas, A. H. Conney, and B. T. Zhu
Characterization of the Oxidative Metabolites of 17{beta}-Estradiol and Estrone Formed by 15 Selectively Expressed Human Cytochrome P450 Isoforms
Endocrinology, August 1, 2003; 144(8): 3382 - 3398.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
R. K. Dubey, D. G. Gillespie, L. C. Zacharia, F. Barchiesi, B. Imthurn, and E. K. Jackson
CYP450- and COMT-Derived Estradiol Metabolites Inhibit Activity of Human Coronary Artery SMCs
Hypertension, March 1, 2003; 41(3): 807 - 813.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2002 by the American Society for Pharmacology and Experimental Therapeutics.